Inogen announces first quarter 2022 financial results

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended march 31, 2022. first quarter 2022 highlights total revenue of $80.4 million, down 7.5% from the same period in 2021, primarily due to supply chain constraints total revenue up 5.2% sequentially from the fourth quarter of 2021 domestic direct-to-consumer revenue of $34.4 mi
INGN Ratings Summary
INGN Quant Ranking